From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Hepatitis B Advanced Online Modules: Part 2 – Management during chemo/immunosuppressive therapy

Course duration
1 hour
Course Type
On Demand
Course duration
1 hour
Course Type
On Demand

These modules introduce concepts regarding the management and treatment of people living with chronic hepatitis B in complex situations.
The modules are split into 3 parts. This is part 2 of 3. To access part 3 click here.

After completing the modules, you will be able to: 

  • Describe risk factors, clinical signs, symptoms and complications of advanced liver disease  
  • Explain why all patients undergoing chemotherapy or immunosuppressive therapy should be screened for hepatitis B 
  • Outline recommendations for the management of women with chronic hepatitis B before, during and after pregnancy 
  • Identify situations where specialist advice or referral is required 

Existing HBV s100 prescribers: Use these modules to refresh your knowledge and contribute to your HBV CPD requirements (1 point for completion of each module). Module completion records will be checked by ASHM staff during the prescriber renewal period, and CPD points allocated accordingly.   

Contact: Please email [email protected] if you require assistance or have a clinical question you would like to raise with a medical educator.    

Target audience: General Practitioners, Nurse Practitioners, Hepatitis B s100 Prescribers   

Last updated: 2019